Skip to main content
logo
Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
137.00
-5.00 (-3.52%)
Sep 24, 2026, 1:30 PM CST

Gongwin Biopharm Holdings Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
42.2236.4532.0418.921.141.14
Revenue Growth
22.49%13.75%69.39%1554.86%0%37.21%
Gross Profit
26.6426.098.6811.21.071.08
Operating Income
-241.17-207.29-162.06-133.33-260.68-120.83
Net Income
-164.52-114.13-82.55-92.04-292.13-121.58
Earnings Per Share
-1.35-0.92-0.68-0.81-2.63-1.11
EPS Growth
------

Revenue by Geography
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Taiwan
1.561.38--1.141.14
Hong Kong and Mainland China
40.1135.0731.9318.92--
Singapore
--0.11---
Total
42.2236.4532.0418.921.141.14

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,5111,6662,209942.251,106826.33
Total Debt
149.93129.74126.7577.17141.74115.14
Net Cash (Debt)
1,3611,5362,082865.08963.87711.19
Net Cash Growth
-8.83%-26.22%140.73%-10.25%35.53%-29.07%
Net Cash Per Share
11.1412.4517.247.648.676.49

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-195.87-135.75-87.41-110.8-232.2-95.51
Capital Expenditures
-2.41-1.86-205.89-0.91-7.34-123.01
Free Cash Flow
-198.28-137.62-293.3-111.7-239.54-218.52
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
63.09%71.58%27.09%59.21%93.26%94.31%
Operating Margin
-571.17%-568.76%-505.80%-704.87%-22806.74%-10570.95%
Pretax Margin
-417.11%-331.64%-286.69%-534.89%-25558.44%-10036.75%
Profit Margin
-389.63%-313.14%-257.64%-486.58%-25558.44%-10637.01%
FCF Margin
-469.60%-377.59%-915.41%-590.55%-20956.69%-19118.11%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
392.99289.68448.481105.5031611.2427212.59